Epirubicin for the Treatment of Sepsis & Septic Shock
Clinical trial NCT05033808 · UNKNOWN
Trial details
- NCT number
- NCT05033808
- Sponsor
- Jena University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-19
- Primary completion
- 2024-10-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.